Search

Your search keyword '"Mesropian, Agavni"' showing total 24 results
Start Over Author "Mesropian, Agavni" Publisher american association for cancer research (aacr)
24 results on '"Mesropian, Agavni"'

1. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

2. Data from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

3. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Data from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

6. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

7. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

8. Supplementary Data from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

22. Data from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., primary, Piqué-Gili, Marta, primary, Montironi, Carla, primary, Abril-Fornaguera, Jordi, primary, Peix, Judit, primary, Torrens, Laura, primary, Mesropian, Agavni, primary, Balaseviciute, Ugne, primary, Miró-Mur, Francesc, primary, Mazzaferro, Vincenzo, primary, Pinyol, Roser, primary, and Llovet, Josep M., primary

Published
2023
Full Text
View/download PDF

24. Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Author

Esteban-Fabró, Roger, primary, Willoughby, Catherine E., additional, Piqué-Gili, Marta, additional, Montironi, Carla, additional, Abril-Fornaguera, Jordi, additional, Peix, Judit, additional, Torrens, Laura, additional, Mesropian, Agavni, additional, Balaseviciute, Ugne, additional, Miró-Mur, Francesc, additional, Mazzaferro, Vincenzo, additional, Pinyol, Roser, additional, and Llovet, Josep M., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results